Hydroxocobalamin administration for treatment of vasoplegic syndrome associated with cardiopulmonary bypass causes red plasma

Transfusion. 2020 Mar;60(3):447-448. doi: 10.1111/trf.15615. Epub 2019 Dec 12.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Cardiopulmonary Bypass / adverse effects*
  • Female
  • Humans
  • Hydroxocobalamin / administration & dosage*
  • Hydroxocobalamin / therapeutic use*
  • Middle Aged
  • Vasoplegia / drug therapy*

Substances

  • Hydroxocobalamin